Literature DB >> 19682430

MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.

Qing Yao1, Hui Xu, Qian-Qian Zhang, Hui Zhou, Liang-Hu Qu.   

Abstract

MicroRNAs are involved in cancer-related processes. The microRNA-21(miR-21) has been identified as the only miRNA over-expressed in a wide variety of cancers, including cervical cancer. However, the function of miR-21 is unknown in cervical carcinomas. In this study, we found that the inhibition of miR-21 in HeLa cervical cancer cells caused profound suppression of cell proliferation, and up-regulated the expression of the tumor suppressor gene PDCD4. We also provide direct evidence that PDCD4-3'UTR is a functional target of miR-21 and that the 18bp putative target site can function as the sole regulatory element in HeLa cells. These results suggest that miR-21 may play an oncogenic role in the cellular processes of cervical cancer and may serve as a target for effective therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682430     DOI: 10.1016/j.bbrc.2009.08.044

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  92 in total

1.  Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.

Authors:  Arti B Gaur; Susan L Holbeck; Nancy H Colburn; Mark A Israel
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  MicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1.

Authors:  Yumei Li; Limei Yan; Wenyu Zhang; Nan Hu; Wei Chen; Hui Wang; Min Kang; Hesheng Ou
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 3.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

4.  MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits.

Authors:  J-E Lee; E-J Hong; H-Y Nam; J-W Kim; B-G Han; J-P Jeon
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

Review 5.  Regulating miRNA by natural agents as a new strategy for cancer treatment.

Authors:  Sajiv Sethi; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

6.  MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.

Authors:  Chenggang Wang; Ren Ren; Haolin Hu; Changjun Tan; Miao Han; Xiaolin Wang; Yun Zheng
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

7.  MicroRNA-21 down-regulates inflammation and inhibits periodontitis.

Authors:  Wei Zhou; Li Su; Xingyu Duan; Xi Chen; Aislinn Hays; Satya Upadhyayula; Juili Shivde; Huizhi Wang; Yong Li; Dingming Huang; Shuang Liang
Journal:  Mol Immunol       Date:  2018-06-06       Impact factor: 4.407

8.  Placental Stem Villus Arterial Remodeling Associated with Reduced Hydrogen Sulfide Synthesis Contributes to Human Fetal Growth Restriction.

Authors:  Liangjian Lu; John Kingdom; Graham J Burton; Tereza Cindrova-Davies
Journal:  Am J Pathol       Date:  2017-02-01       Impact factor: 4.307

9.  microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer.

Authors:  Xiaoyan Qin; Lei Yan; Xingbo Zhao; Chunyan Li; Yibing Fu
Journal:  Oncol Lett       Date:  2012-09-06       Impact factor: 2.967

10.  Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.

Authors:  Jun Zhang; Tingting Yao; Yaxian Wang; Jin Yu; Yunyun Liu; Zhongqiu Lin
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.